Viewing StudyNCT05836623



Ignite Creation Date: 2024-05-06 @ 6:55 PM
Last Modification Date: 2024-10-26 @ 2:57 PM
Study NCT ID: NCT05836623
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-28
First Post: 2023-03-07

Brief Title: A Phase I Study to Assess PSMA and PSMA- Tumour Lesions
Sponsor: Crescendo Biologics Ltd
Organization: Crescendo Biologics Ltd

Conditions & Keywords Data

Conditions:
Name
Advanced andor Metastatic Solid Tumours
Keywords:
Name View
HSA View
Phase 1 Study View
Solid Tumours View
Castration-resistant prostate cancer CRPC View
Prostate Specific Membrane Antigen PSMA View
Crescendo Biologics View
CD137 View
CB307 View
Humabody View
Radiolabelled CB307 View
89-Zirconium View
Biodistribution View